about
Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications.Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS)Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesHDAC inhibitor-based therapies and haematological malignancy.Lenalidomide: a review of its use in the treatment of relapsed or refractory multiple myeloma.The evolving use of arsenic in pharmacotherapy of malignant disease.Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.
P2860
Q34072984-97D95FAC-4093-465B-8EFB-BF3065BC3BEAQ36342992-526F34FD-93E4-4759-B181-F84B26327ECDQ37182794-310F1411-EB3A-4669-8D44-9D297E7FDC38Q37514642-3A3C40A7-E1F0-4387-9FC7-D2FDC8841ACCQ37858523-A2D14D9B-9140-4C82-8F02-426191790FFDQ38089629-124EACB9-DA90-4CEB-B974-F3E793C96266Q42443356-A9DA7F0A-A3A0-4CF2-A956-4CDC781D2357
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Novel therapies in myeloma.
@en
type
label
Novel therapies in myeloma.
@en
prefLabel
Novel therapies in myeloma.
@en
P1476
Novel therapies in myeloma.
@en
P2093
Constantine S Mitsiades
Patrick J Hayden
P304
P356
10.1097/MOH.0B013E3282F0E948
P577
2007-11-01T00:00:00Z